Evidence Level
Peppermint oil is a well-supported herbal therapy for irritable bowel syndrome (IBS), backed by robust evidence from multiple meta-analyses. A systematic review and meta-analysis by Khanna et al. (2014) of nine studies involving 726 patients demonstrated that enteric-coated peppermint oil significantly improved global IBS symptoms and abdominal pain compared to placebo, with only mild transient adverse effects. Similarly, a 2022 systematic review and meta-analysis by Ingrosso et al. confirmed the efficacy of peppermint oil in reducing IBS-related discomfort.
The mechanism of action involves L-menthol, which blocks calcium channels in intestinal smooth muscle and activates TRPM8 cold receptors on visceral neurons, thereby alleviating visceral hypersensitivity (Madisch et al., 2023). Enteric coating is essential to prevent heartburn caused by relaxation of the lower esophageal sphincter.
Peppermint oil's benefits extend beyond IBS. A systematic review and meta-analysis by Aziz et al. (2020) found that peppermint oil reduces spasticity (-0.39, P=0.02), severe spasticity (-0.15, P=0.04), and peristalsis (-0.27, P≤0.001) during colonoscopy, while improving adenoma detection rates (RR: 1.31, P=0.01). These findings highlight its broader potential in gastrointestinal care.
The American College of Gastroenterology (ACG) and the American Gastroenterological Association (AGA) recognize peppermint oil as a valuable treatment option for IBS in their clinical guidelines. Overall, peppermint oil offers a safe and effective natural therapy supported by robust evidence across multiple indications.